Reuters logo
AstraZeneca offers no comment after report saying CEO staying
2017年7月14日 / 晚上7点08分 / 4 个月前

AstraZeneca offers no comment after report saying CEO staying

LONDON, July 14 (Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca declined to comment on speculation about the future of its chief executive Pascal Soriot on Friday, after a report quoted Bloomberg news agency saying he would stay in his post.

The StreetInsider.com, citing Bloomberg, said Soriot was currently planning to stay for the foreseeable future.

When asked about the report, an AstraZeneca spokeswoman declined to comment, saying the firm had a policy of not responding to market speculation or rumours.

AstraZeneca has repeatedly declined to comment on Wednesday’s Israeli media report saying Soriot was in talks to join Israel’s Teva Pharmaceutical Industries. Uncertainty over his future has hit AstraZeneca’s shares.

Reporting by Paul Sandle; Editing by Edmund Blair

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below